HBHelga Bronner

Helga Bronner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Helga Bronner has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identification of a NUAK1/2 Inhibitor as a Macrophage-Polarizing Compound by a Machine Learning-Based Phenotypic Cell Painting Screen

    by Johanna B. Brüggenthies-Brunner, Jakob Dittmer, Julia Sauer, Sarah Groetzner, Anika Liu, Eva Martin, Anja Teufel, Christine Strasser, Helga Bronner, Robert Ries, et al.

    Disease-associated macrophage states contribute to the pathogenesis of numerous inflammatory disorders. While small molecule-mediated macrophage repolarization represents a promising strategy to restore homeostasis, current approaches often rely on predefined molecular markers and may therefore overlook previously unrecognized modulators of macrophage plasticity. To address this limitation, we performed a phenotypic high-content cell painting screen in induced pluripotent stem cell-derived and blood monocyte-derived macrophages. Using our previously established machine learning-based cell painting analysis pipeline, we screened the annotated opnMe and JUMP-CP compound libraries and identified 26 compounds that induced M1- or M2-like polarization phenotypes. Among these hits, we identified WZ4003, an inhibitor of AMPK-related kinases NUAK1 and NUAK2, as novel macrophage-polarizing compound. Combining cell painting feature profiling with functional analyses, we revealed that the NUAK1/2 inhibitor WZ4003 induces a distinct macrophage state characterized by a rounded M1-like morphology, ferroptosis protection, mitochondrial reactive oxygen species increase, antioxidative adaptation, and phagocytosis and efferocytosis impairment. These findings link specific morphological signatures to functional macrophage states. Overall, this study provides a resource of macrophage-polarizing compounds and demonstrates the utility of machine learning-based cell painting for identifying novel modulators of macrophage polarization states.

  • Open Access

    Insights into the Identification of iPSC- and Monocyte-Derived Macrophage-Polarizing Compounds by AI-Fueled Cell Painting Analysis Tools

    by Johanna B. Brüggenthies, Jakob Dittmer, Eva Martin, Igor Zingman, Ibrahim Tabet, Helga Bronner, Sarah Groetzner, Julia Sauer, Mozhgan Dehghan Harati, Rebekka Scharnowski, et al.

    Macrophage polarization critically contributes to a multitude of human pathologies. Hence, modulating macrophage polarization is a promising approach with enormous therapeutic potential. Macrophages are characterized by a remarkable functional and phenotypic plasticity, with pro-inflammatory (M1) and anti-inflammatory (M2) states at the extremes of a multidimensional polarization spectrum. Cell morphology is a major indicator for macrophage activation, describing M1(-like) (rounded) and M2(-like) (elongated) states by different cell shapes. Here, we introduced cell painting of macrophages to better reflect their multifaceted plasticity and associated phenotypes beyond the rigid dichotomous M1/M2 classification. Using high-content imaging, we established deep learning- and feature-based cell painting image analysis tools to elucidate cellular fingerprints that inform about subtle phenotypes of human blood monocyte-derived and iPSC-derived macrophages that are characterized as screening surrogate. Moreover, we show that cell painting feature profiling is suitable for identifying inter-donor variance to describe the relevance of the morphology feature ‘cell roundness’ and dissect distinct macrophage polarization signatures after stimulation with known biological or small-molecule modulators of macrophage (re-)polarization. Our novel established AI-fueled cell painting analysis tools provide a resource for high-content-based drug screening and candidate profiling, which set the stage for identifying novel modulators for macrophage (re-)polarization in health and disease.